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The C1s protease of the classical complement pathway propagates the initial activation
of this pathway of the system by cleaving and thereby activating the C4 and C2 comple-
ment components. This facilitates the formation of the classical pathway C3 convertase
(C4bC2a). C1s has a Lys residue located at position 628 (192 in chymotrypsin numbering) of
the SP domain that has the potential to partially occlude the S2–S2′ positions of the active
site. The 192 residue of serine proteases generally plays an important role in interactions
with substrates. We therefore investigated the role of Lys628 (192) in interactions with C4
by altering the Lys residue to either a Gln (found in many other serine proteases) or an Ala
residue. The mutant enzymes had altered specificity profiles for a combinatorial peptide
substrate library, suggesting that this residue does influence the active site specificity of
the protease. Generally, the K628Q mutant had greater activity than wild type enzyme
against peptide substrates, while the K628A residue had lowered activity, although this
was not always the case. Against peptide substrates containing physiological substrate
sequences, the K628Q mutant once again had generally higher activity, but the activity
of the wild type and mutant enzymes against a C4 P4–P4′ substrate were similar. Inter-
estingly, alteration of the K628 residue in C1s had a marked effect on the cleavage of C4,
reducing cleavage efficiency for both mutants about fivefold.This indicates that this residue
plays a different role in cleaving protein versus peptide substrates and that the Lys residue
found in the wild type enzyme plays an important role in interacting with the C4 substrate.
Understanding the basis of the interaction between C1s and its physiological substrates
is likely to lead to insights that can be used to design efficient inhibitors of the enzyme for
use in treating diseases caused by inflammation as result of over-activity of the classical
complement pathway.
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INTRODUCTION
The complement system is of major importance in innate and
adaptive immunity (1), but has also been shown to play a major
role in several inflammatory diseases (2, 3). Understanding the
precise mechanisms whereby the pathways of the system are acti-
vated is therefore likely to provide understanding of potential
mechanisms to control the system. Once activated following the
recognition and initial activation events of the classical pathway,
C1s plays a major role in amplifying the initial recognition by
cleaving and thus activating the C4 and C2 complement proteins
that go on to form the C4bC2a C3 convertase complex (4, 5). It has
recently been shown that the activation of the C1s protease is con-
comitant with the formation of an exosite on the serine protease
domain (6, 7) that works in concert with a likely exosite on the
CCP domains and the active site to efficiently catalyze the cleav-
age of C4 to yield the C4b and C4a fragments. In this regard, the
interaction between C1s and C4 is likely to have similarity to the
MASP-2-C4 interaction, which has been elucidated structurally
(8) and biochemically (9–11). Given that the exosite interactions
for the classical and lectin pathway proteases are somewhat similar,
the focus falls on the active sites of the proteases in order to provide
selective inhibitors of the pathways for use in controlling diseases
in which they are involved.
The X-ray crystal structure of the activated CCP2-SP form of
C1s (12) shows that the active site of the enzyme is quite “closed”
and restricted from its surrounding environment, which most
likely contributes to its high level of substrate specificity (13).
During the cleavage of C4, C1s must accommodate a bulky P2 Gln
into a relatively small S2 subsite. To date, there is no X-ray crystal
structure of C1s with a peptide substrate bound in the active site,
and therefore, it is unknown how the protease finds the capacity
to accommodate such a large amino acid. The Lys628 (192 in chy-
motrypsin numbering) is a dominant feature of the active site, as it
overlaps the entrance to the crucial S2–S2′ subsites of the enzyme
(12) (Figure 1).
The K628 (K192 in chymotrypsin numbering) amino acid has
been shown to be vital in many serine proteases. Only 14% of
trypsin-like proteases in the human genome contain a lysine at
position 192, while 60% contain glutamine and 5.4% glutamate
(14). Previous studies in which serine proteases were mutated at
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FIGURE 1 | Superposition of active C1s (gray) (PDB ID: 1ELV) in surface
representation, on the structure of the MASP-2 – C4 complex (C4 in
navy blue) (PDB ID: 4FXG) in cartoon representation. The position of
K628 (orange) is highlighted with respect to the P4–P4′ cleavage loop of C4
(in teal, P1 arginine sidechain shown in stick). The panels on the right
represent the structure in the same orientation with the K628 position
mutated to an alanine (top panel) and glutamine (bottom panel).
position 192 have shown that mutation of this residue can have a
variety of effects on the interaction of chymotrypsin-family serine
proteases with substrates and inhibitors (14–16).
Here, we have mutated this residue in C1s to Gln and Ala in
order to understand its role in the interaction with peptide sub-
strates and C4. The results indicate that the Lys residue at this
position in the protease plays a role in facilitating efficient cleavage
of C4 in particular.
MATERIALS AND METHODS
PRODUCTION OF RECOMBINANT C1s AND MUTANTS
Recombinant human C1s and the K628Q and K628A mutants were
expressed in Escherichia coli as insoluble proteins in the inclusion
bodies as described previously (7). The enzymes were denatured
and then refolded, following which they were purified by a combi-
nation of anion exchange and gel filtration chromatography all as
previously described (7). All proteins were obtained in good yield
and purity. The zymogen forms of the proteases were activated
using immobilized C1r as previously described (7). The activated
proteases were titrated using C1-inhibitor (CompTech, TX, USA)
to yield the final active concentrations of each enzyme form.
CLEAVAGE OF THE REPLi COMBINATORIAL SUBSTRATE LIBRARY BY
C1s ENZYMES
Wild type or mutant C1s forms (400 nM) were tested for their
ability to cleave a combinatorial peptide substrate library (REPLi,
Mimotopes, Clayton, VIC, Australia) containing 3375 different
peptides arranged in 512 pools (17). The assays were conducted in
fluorescence assay buffer (FAB) [50 mM Tris–HCl, 150 mM NaCl,
0.2% (w/v) PEG 8000, pH 7.4] at 37°C. Cleavage of the substrates
was monitored by measuring the increase in fluorescence intensity
from the MeOC fluorophores using 55 s cycles for 30 cycles, with
an excitation wavelength of 320 nm and an emission wavelength
of 420 nm. The initial velocity of the cleavage was indicated by the
slope per unit time of the linear region of the curves.
CLEAVAGE OF PEPTIDE SUBSTRATES CONTAINING PHYSIOLOGICAL
SEQUENCES
Assays were carried out in FAB at 37°C using final sub-
strate concentrations in the range of 0.5–500µM. The fluores-
cence quenched C4 P4–P4′ substrate (FQS) [2-aminobenzoate-
GLQRALEI-Lys(Dinitrophenol)-NH2] and coumarin substrates
{C2 P3-P1 substrate [Z-LGR-aminomethylcoumarin (AMC)] and
C4 P5-P1 substrate [Z-AGLQR-AMC]} were solubilized in 10%
(v/v) dimethylformamide. The rate of increase of fluorescence
in the presence of 400 nM C1s (wild type or mutant) was mea-
sured on a BMG Technologies FluoStar Galaxy fluorescent plate
reader (BMG Labtech, Offenburg, Germany) using an excitation
wavelength of 320 nm and an emission wavelength of 420 nm
for the FQS and 360/460 nm for coumarin substrates. The ini-
tial reaction rate was estimated at a single concentration of
enzyme from duplicate measurements over a range of substrate
concentrations. In order to determine steady-state reaction con-
stants [V max (maximal velocity) and K 0.5 (half saturation con-
stant)], the experimental results were fitted, using the GraphPad
Prism Version 5.0 computer program (GraphPad Software, San
Diego, CA, USA), to an equation describing positive cooperativity
(V = V max[S]h/[S]h + [K 0.5]h), which defines the relationship
between reaction rate (V ) and substrate concentration ([S]) when
more than one binding site applies (18). The catalytic efficiency
(kcat) values were calculated as described previously (18).
CLEAVAGE OF C4
C4 (CompTech, TX, USA) at 1µM (final concentration) was incu-
bated with increasing concentrations of C1s or mutants (0–5 nM)
for 1 h in FAB at 37°C. Reactions were stopped by the addition
of reducing SDS-loading buffer and samples were incubated at
90°C for 5 min, then loaded onto 12.5% SDS-PAGE and elec-
trophoresed. Gels were stained with Coomassie blue R-250 stain
and destained. The cleavage of the C4 alpha band was analyzed
using the gamma band as a loading control. A Typhoon Trio (488,
532, and 632 nm lasers) was utilized for densitometry analysis
using the IQTL ImageQuant™ software (1D Gel Analysis) (GE
Healthcare, Australia). The densitometry data for the disappear-
ance of the alpha band of C4 was plotted against the log of the
concentration of C1s used. The EC50 values were derived by fit-
ting the data using non-linear regression to the following equation:
Y = Y min+ (Y max−Y min)/{1+ 10[(LogEC50−X)*h)]}, where Y min
is the minimum Y -value, Y max is the maximum Y -value, and h
is the Hill slope. The analysis was carried out using GraphPad
Prism, which output 95% confidence intervals for each value that
indicated that the value obtained for the wild type enzyme was sig-
nificantly different from those obtained for the mutant forms at
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a 95% confidence level. The experiment was repeated three times
with similar results obtained.
The time course of cleavage of C4 (1µM) by C1s forms at
1 nM was derived by incubating the components for 0, 1, 2, 5, 15,
30, 60, and 120 min, following which the reaction mixtures were
treated as described above. The disappearance of the alpha band
was quantified by densitometry as specified above.
RESULTS
The REPLi peptide substrate library provides a rapid means
of investigating the substrate specificity of a protease. We have
previously characterized the substrate specificity of C1s using a
phage display-based analysis (13), which yielded a highly cleaved
sequence, YLGR-SYKV, consistent with the preference of this
enzyme for a small amino acid, such as Gly, at P2 and a hydropho-
bic amino acid, such as Leu, at P3. The top ranked substrate for
C1s in the REPLi library had the form K/R-S/T-I/L (Figure 2).
Since C1s is highly specific for Arg residues at P1 in particular, we
can assume this substrate would be cleaved after the K/R position.
Since Gly residues occupy all positions other than those being var-
ied in these substrates, this would be the residue found at P2 in
this substrate. The strong preference of C1s for P2′ Leu and P1′
Ser residues has also been noted before and the sequence overall is
similar to that found at the P1–P2′ of C1-inhibitor, with C4 also
having a Leu at P2′.
Overall, the K628Q enzyme mutant was much more active
against substrate pools in general than the wild type enzyme, while
in general the K628A mutant was less active than the wild type
enzyme. This was not true for substrates with a Pro residue at the
likely P2 position, which the K628A mutant cleaved better than
wild type in general, although less well than the K628Q mutant.
The K628A mutant was also more active against the K/R-A/V-K/R
pool than wild type. While it cannot be certain where the enzyme
would cleave in this substrate, as there are two potential Arg
residues that may constitute the P1 residue, there is a likelihood
that the second K/R residue would lie within P2′, and thus, it
appears that the absence of K628 favors cleavage of this substrate
pool. In support of this, the wild type enzyme cleaved the K/R-A/V-
D/E pool more rapidly than either mutant. In that case, the D/E
residue must sit at P2′ and it appears that the positively charged
K628 favors interaction with the oppositely charged D/E residue.
Thus, it appears that the K628 residue might indeed be able to
interact with the P2′ residues of substrates.
It is worthy of note that the enzyme essentially did not cleave
substrates of the form K/R-K/R-I/L (the P1–P2′ sequence of C2),
N/Q-K/R-A/V (the P2–P1′ sequence of C4), or I/L-N/Q-K/R (P3–
P1 of C4). This indicates that the Lys residue found at the P1′
position in C2 and the Gln residue found at the P2 position of C4
are likely to be prohibitive for cleavage of substrates by C1s. How-
ever, the K628Q and K628A mutants of C1s also did not cleave
these substrate pools, indicating that K628 does not play a crucial
role in preventing interaction with such substrates.
The results obtained with the REPLi peptide substrate library
suggested that the K628 residue of C1s plays a role in restricting
the substrate specificity of C1s for peptide substrates. In general,
the replacement of the Lys residue with the Gln residue found at
this position in many other serine proteases increased the cleavage
rate of the enzyme for many pools of substrates, while replacement
with an Ala had the opposite effect. This general trend was also
observed with the Z-LGR-AMC and Z-AGLQR-AMC peptide sub-
strates, representing the P3–P1 and P5–P1 sequences of C2 and C4,
respectively (Table 1). The kcat/K 0.5 value for the K628Q mutant
with Z-LGR-AMC was fivefold higher than that for wild type, while
the same parameter for K628A was twofold decreased compared
FIGURE 2 | Bar graphs of the initial velocity values for substrate pools of
the REPLi combinatorial peptide substrate library incubated with wild
type and K628 mutants of C1s. The identity of the three amino acid
positions varied for each pool displayed is shown above each graph. Initial
velocity values for wild type (empty bar), K628A (lighter hatched bar), and
K628Q (dark hatched bar) are shown.
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Table 1 | Kinetic parameters for cleavage of peptide substrates by wild type C1s and K628 mutants.
Substrate and parameter Wild type C1s C1s K628Q C1s K628A
Z-LGR-AMC K 0.5 (µM) 169±7.9 76.2±1.15 212±13.8
kcat (s−1) 2.72 6.0 1.77
kcat/K 0.5 (M−1s−1) 1.6×104 7.9×104 8.3×103
Z-AGLQR-AMC K 0.5 (µM) 245±13.3 65.4±1.91 109±18.9
kcat (s−1) 35.33 116.5 1.3
kcat/K 0.5 (M−1s−1) 1.4×105 1.8×106 1.2×104
Abz-GLQRALEI-Lys(Dnp) K 0.5 (µM) 13.8±0.3 12.3±0.49 12.0±0.6
kcat (s−1) 1.14 1.17 1.3
kcat/K 0.5 (M−1s−1) 8.2×104 9.5×104 1.1×105
C4 EC50 (nM) 0.16 0.76 0.77
FIGURE 3 | Cleavage of C4 by increasing concentrations of wild type and
mutant forms of C1s. The cleavage of C4 (1µM) by the indicated
concentrations of wild type (W), K628A (A), and K628Q (Q) forms of C1s was
allowed to proceed for 1 h, following which the reaction was stopped by the
addition of the loading buffer for SDS-PAGE. The alpha, beta, and gamma
chains of C4 are indicated to the left. The cleaved remnant of the alpha chain
appears as a band immediately below that of the alpha chain. The experiment
was repeated three times with similar results.
to the wild type enzyme. The major determinant of the effects was
the change to the kcat parameter in each case. The kcat/K 0.5 for
the Z-AGLQR-AMC substrate was increased over 10-fold for the
K628Q mutant, while that for the K628A mutant was decreased
over 10-fold. Again, the changes to the kcat parameter were the
major effect noted.
Interestingly, different results were obtained with the Abz-
GLQRALEI-Lys(Dnp) fluorescence quenched peptide represent-
ing the P4–P4′ sequence of C4. In this case, the kcat/K 0.5 values for
wild type versus the K628Q mutant were essentially the same,while
the same parameter for K628A was slightly increased. This indi-
cates that the addition of the prime side residues and the removal
of a very bulky coumarin group from the P1′ position of the sub-
strate had major effects on the interaction of the enzymes with
the substrate, such that all were essentially equal in their ability to
cleave the amino acid sequence found at the cleavage point within
the C4 substrate.
Mutation of the K628 residue to either a Gln or Ala residue
reduced the efficiency of cleavage by approximately fivefold
(Table 1). Thus, at concentrations up to 0.3 nM, the wild
type enzyme cleaved C4 much more efficiently than either
mutant enzyme (Figure 3). The K628Q mutant also cleaved C4
considerably more slowly than the wild type enzyme (Figure 4).
This was also found for the K628A mutant (results not shown).
DISCUSSION
In general, the results obtained with the REPLi library reinforced
previous specificity data for this enzyme (13), although it was
interesting to note that the I/L-S/T-K/R and I/L-A/V-K/R pools
were not well cleaved by the wild type enzyme, somewhat con-
trary to previous data indicating a preference for Leu residues at
the P3 position of substrates for C1s. The mutation of K628 to
an Ala residue did not improve the activity of the enzyme against
such substrates, but the K628Q mutant cleaved these substrate
pools much better, indicating that the mutation to a Gln residue
favored such substrates.
The results with the proposed P2′ residues of substrates are
similar to what was noted for mast cell chymase, where a K192
residue mediated favorable contacts with negatively charged P2′
residues (19) and thrombin, where E192 restricted the specificity
of the enzyme (20). Overall, however, it appears that K628 influ-
ences the substrate specificity of C1s at a number of different
subsites, indicating that the amino acid sidechain might be inter-
acting with amino acids at a number of different positions within a
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FIGURE 4 |Time course of the cleavage of C4 by wild type and K628Q
forms of C1s. The cleavage of C4 (1µM) by 1 nM wild type (black circles)
and K628Q (red squares) forms of C1s was allowed to proceed for 0, 1, 2,
5, 15, 30, 60, and 120 min, following which the reaction was stopped by the
addition of the loading buffer for SDS-PAGE. Following SDS-PAGE analysis,
the disappearance of the alpha chain of C4 was quantified by densitometry
and converted into a value indicating the percentage of cleavage.
peptide substrate. This indicates that the residue might be flexible
in conformation, as was indicated in the structure of activated C1s
previously solved (12).
We have previously shown (7) that the interaction of C1s with
C4 can be assessed using analyses that derive the efficiency con-
stant, EC50, for cleavage of the substrate by the enzyme. Here,
we obtained a somewhat lower EC50 for cleavage of the substrate
by the wild type enzyme than that reported before [0.16 nM here
versus 1 nM reported in Ref. (7)], but nevertheless these efficiency
values are within range of each other. The enzymes also were found
to cleave C4 more slowly than the wild type enzyme. Our data indi-
cates that although the enzymes could cleave the P4–P4′ sequence
of the substrate very similarly, the K628 residue clearly makes an
important interaction with the C4 protein substrate that cannot
be replicated by the polar Gln residue, suggesting that it is the
positive charge of the K628 that is important in this regard. Since
cleavage of a substrate that would be expected to bind within the
active site was not changed (see Results for C4 P4–P4′ FQS), this
would suggest that an interaction between K628 and a substrate
residue external to the active site is occurring.
The amino acid found at the 192 position of chymotrypsin-
family serine proteases has been shown to be critical in the regu-
lation of interactions with substrates and inhibitors (16, 19, 20).
The K628(192) residue of C1s partially occludes the active site by
restricting access to the S1 pocket and therefore changes in the
interaction with substrates were anticipated. However, it should
be noted that in the structure obtained for the active C1s CCP2-
SP, K628 is partially disordered, which may suggest the amino acid
is quite dynamic in nature (12). It is therefore possible that in
the case of the interaction between C1s and C4, the K628 residue
is playing a role outside of the active site and interacting with a
negatively charged residue of the substrate.
We have previously shown that a positively charged exosite
located on the serine protease domain of C1s interacts with a neg-
atively charged site on C4 to yield efficient binding and cleavage
of the substrate molecule by the enzyme (7). It is unlikely that it is
the same negatively charged site of C4 that is interacting with the
Lys628 residue of C1s, but it does suggest that the exosite inter-
actions of the enzyme extend somewhat beyond the originally
defined four amino acids of C1s. In the structure of the related
MASP-2 enzyme in complex with C4 (8), the Arg residue at the
192 position of this enzyme (630 in numbering of residues in
the MASP-2 structure) lies very close to the loop that is cleaved
in C4, but it appears to be making little direct contact with the
substrate, thus examination of this complex does not provide any
obvious clues as to the possible interactions that the K628 residue
of C1s might be making. It should be noted that the active site
architecture of C1s is markedly different at this position com-
pared to MASP-2, however (12, 21). Modeling of the C1s into the
same position as the MASP-2 in this structure (Figure 1) does
not provide any further insights, suggesting that the residue may
have to change orientation considerably to be able to achieve the
new interactions suggested by the data obtained here. In the struc-
ture of the zymogen form of C1s (6), this residue faces inwards
and away from possible substrate contacts, suggesting that it too
is structurally removed from possible substrate interactions, in
common with the “main” exosite of the serine protease domain
of C1s, which is structurally altered in the zymogen form so that
interactions with substrates are minimized in this form of the
enzyme.
The studies carried out here give additional insight into the
interactions mediated by the K628 residue of C1s. They suggest
that in the specific case of the C4 substrate, the residue is playing
a role outside of the active site interactions with substrates. How-
ever, equally it is clear that the residue can affect the functioning
of the enzymes active site in cleaving peptide substrates and thus
it must be considered when designing molecules to interact with
the active site of the enzyme in order to inhibit it. Such mole-
cules would be expected to have uses in counteracting a number
of inflammatory diseases.
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